SCHEMBL4969024

SCHEMBL4969024

CC(C)N[C@H](C(=O)NCC(c1ccccc1)(c1ccc(F)cc1)c1cc(F)cc(C(F)(F)F)c1)C(O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.66

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CETP P11597 7/20 0.66
KCNH2 Q12809 4/20 0.66
TACR1 P25103 8/20 0.37
CCR2 P41597 3/20 0.36
SLC6A9 P48067 1/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
P2RX1 P51575 1/20 0.35
TACR3 P29371 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971187 0.90 CETP (0.65) CETPKCNH2TACR1CCR2SLC6A9
SCHEMBL760260 0.79 CETP (1.00) CETPKCNH2
SCHEMBL760800 0.79 CETP (1.00) CETPKCNH2
SCHEMBL4969174 0.78 CETP (0.48) CETPKCNH2TACR1SLC6A9MEN1
SCHEMBL4966775 0.78 CETP (0.43) CETPKCNH2TACR1CCR2SLC6A9
SCHEMBL4967551 0.78 CETP (0.43) CETPKCNH2TACR1CCR2SLC6A9
SCHEMBL4970220 0.78 CETP (0.43) CETPKCNH2TACR1CCR2SLC6A9
SCHEMBL14244185 0.73 CETP (0.61) CETPKCNH2TACR1CCR2
SCHEMBL14244186 0.73 CETP (0.61) CETPKCNH2TACR1CCR2
SCHEMBL4721472 0.72 CETP (0.41) CETPKCNH2SLC6A9MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed